Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review
Amélie Anota, Astrid Pozet, H. Lemasson, François-Emery Cotté, Antoine Falcoz, Guillaume Eberst, Guillaume Mouillet, Stéphane Guerzider, Émilie Charton, Virginie Westeel
Topics & Concepts
MedicineClinical trialRandomized controlled trialMeta-analysisMEDLINECochrane LibraryInternal medicineCancerSystematic reviewResearch designClinical study designPhysical therapyOncologySociologyPolitical scienceLawSocial scienceStatistical Methods in Clinical TrialsAdvanced Causal Inference TechniquesCancer Immunotherapy and Biomarkers